Striatal Dopamine Transporter Function Is Facilitated by Converging Biology of α-Synuclein and Cholesterol.

Parkinson’s disease alpha-synuclein (SNCA) cholesteroI dopamine transporter (DAT) dopamine uptake early stage parkinsonism galactoceramide striatum

Journal

Frontiers in cellular neuroscience
ISSN: 1662-5102
Titre abrégé: Front Cell Neurosci
Pays: Switzerland
ID NLM: 101477935

Informations de publication

Date de publication:
2021
Historique:
received: 25 01 2021
accepted: 22 03 2021
entrez: 3 5 2021
pubmed: 4 5 2021
medline: 4 5 2021
Statut: epublish

Résumé

Striatal dopamine transporters (DAT) powerfully regulate dopamine signaling, and can contribute risk to degeneration in Parkinson's disease (PD). DATs can interact with the neuronal protein α-synuclein, which is associated with the etiology and molecular pathology of idiopathic and familial PD. Here, we tested whether DAT function in governing dopamine (DA) uptake and release is modified in a human-α-synuclein-overexpressing (

Identifiants

pubmed: 33935654
doi: 10.3389/fncel.2021.658244
pmc: PMC8081845
doi:

Types de publication

Journal Article

Langues

eng

Pagination

658244

Subventions

Organisme : Medical Research Council
ID : MR/P007058/1
Pays : United Kingdom
Organisme : Parkinson's UK
ID : K-1003
Pays : United Kingdom
Organisme : Parkinson's UK
ID : G-1003
Pays : United Kingdom
Organisme : Parkinson's UK
ID : G-0808
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/D012910/1
Pays : United Kingdom
Organisme : Parkinson's UK
ID : G-1103
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K013866/1
Pays : United Kingdom
Organisme : Parkinson's UK
ID : H-1102
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M024962/1
Pays : United Kingdom
Organisme : Parkinson's UK
ID : H-1301
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/J004324/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_EX_MR/N50192X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L023784/2
Pays : United Kingdom
Organisme : Parkinson's UK
ID : G-0801
Pays : United Kingdom
Organisme : Parkinson's UK
ID : G-1305
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0700932
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0400144
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N029453/1
Pays : United Kingdom
Organisme : Alzheimer's Society
ID : 182
Pays : United Kingdom
Organisme : Parkinson's UK
ID : G-1504
Pays : United Kingdom
Organisme : Parkinson's UK
ID : H-1003
Pays : United Kingdom
Organisme : Parkinson's UK
ID : J-0901
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V013599/1
Pays : United Kingdom
Organisme : Parkinson's UK
ID : G-0803
Pays : United Kingdom

Informations de copyright

Copyright © 2021 Threlfell, Mohammadi, Ryan, Connor-Robson, Platt, Anand, Serres, Sharp, Bengoa-Vergniory, Wade-Martins, Ewing, Cragg and Brimblecombe.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Neurosci. 2010 Mar 3;30(9):3398-408
pubmed: 20203199
Front Neurosci. 2018 Mar 14;12:161
pubmed: 29593491
Trends Neurosci. 2004 May;27(5):270-7
pubmed: 15111009
PLoS One. 2011;6(12):e27959
pubmed: 22163275
J Neurochem. 2018 Jan;144(2):162-171
pubmed: 29168892
J Neurochem. 2007 Apr;101(1):132-41
pubmed: 17250686
J Biol Chem. 2010 Oct 15;285(42):32616-26
pubmed: 20688912
Basal Ganglia. 2016 Aug;6(3):123-148
pubmed: 27141430
J Physiol. 2014 Aug 15;592(16):3559-76
pubmed: 24973407
Nat Commun. 2020 Sep 28;11(1):4885
pubmed: 32985503
Neurochem Int. 2006 Apr;48(5):329-40
pubmed: 16406146
Front Comput Neurosci. 2013 Mar 18;7:13
pubmed: 23515615
Trends Pharmacol Sci. 1999 Oct;20(10):424-9
pubmed: 10498956
J Neurosci. 2014 Aug 6;34(32):10603-15
pubmed: 25100594
FASEB J. 2001 Apr;15(6):916-26
pubmed: 11292651
Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):E4016-25
pubmed: 24082145
Environ Health Perspect. 2009 Jun;117(6):964-9
pubmed: 19590691
Science. 2003 Oct 31;302(5646):841
pubmed: 14593171
Anal Chem. 2018 Jul 17;90(14):8509-8516
pubmed: 29912552
J Biol Chem. 2011 Dec 23;286(51):43933-43943
pubmed: 21990355
Nat Commun. 2013;4:2720
pubmed: 24193139
Trends Pharmacol Sci. 2013 Sep;34(9):489-96
pubmed: 23968642
Nat Commun. 2019 Sep 19;10(1):4263
pubmed: 31537790
Cell Rep. 2012 Jul 26;2(1):33-41
pubmed: 22840394
J Neurosci. 1997 Feb 1;17(3):960-74
pubmed: 8994051
Neurosci Lett. 2003 Apr 17;340(3):189-92
pubmed: 12672538
Neuron. 2012 Jul 12;75(1):58-64
pubmed: 22794260
J Nucl Med. 2009 Jan;50(1):45-52
pubmed: 19091889
Front Cell Neurosci. 2019 May 01;13:175
pubmed: 31118888
Front Neurosci. 2020 Jan 29;14:18
pubmed: 32063829
Molecules. 2017 Oct 19;22(10):
pubmed: 29048372
Neuropharmacology. 2018 May 1;133:289-306
pubmed: 29407218
Nat Neurosci. 2004 Jun;7(6):583-4
pubmed: 15146188
Acta Neuropathol Commun. 2014 Oct 29;2:150
pubmed: 25358962
Neuron. 2000 Jan;25(1):239-52
pubmed: 10707987
Cell Calcium. 2015 Nov;58(5):457-66
pubmed: 26162812
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1931-6
pubmed: 26839413
Neurobiol Dis. 2015 Feb;74:66-75
pubmed: 25447236
J Neurochem. 2012 Dec;123(5):700-15
pubmed: 22957537
Eur J Neurosci. 2008 Feb;27(4):947-57
pubmed: 18333965
J Phys Chem B. 2017 Apr 20;121(15):3657-3666
pubmed: 28118712
J Neurosci. 2006 Mar 22;26(12):3206-9
pubmed: 16554471
Brain Res. 2011 Mar 25;1382:37-44
pubmed: 21276428
J Parkinsons Dis. 2017;7(3):433-450
pubmed: 28671142
Front Neurosci. 2019 Apr 11;13:328
pubmed: 31031582
Neurobiol Aging. 2017 Mar;51:54-66
pubmed: 28038352
Genesis. 2006 Aug;44(8):383-90
pubmed: 16865686
Neuropharmacology. 2007 Jun;52(8):1596-605
pubmed: 17459426
Trends Neurosci. 2007 May;30(5):244-50
pubmed: 17418429
Acta Neuropathol. 2019 Nov;138(5):681-704
pubmed: 31006067
Semin Cell Dev Biol. 2021 Apr;112:123-136
pubmed: 32773177
J Neurosci. 2018 Jan 10;38(2):484-497
pubmed: 29175958
FEBS J. 2018 Oct;285(19):3657-3668
pubmed: 30028088
J Neurosci. 2020 Nov 4;40(45):8767-8779
pubmed: 33046544
ACS Chem Neurosci. 2019 Aug 21;10(8):3419-3426
pubmed: 31361457
Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3213-9
pubmed: 22315428
J Neurosci. 2010 Jul 21;30(29):9762-70
pubmed: 20660258
Neuron. 2009 Apr 30;62(2):218-29
pubmed: 19409267

Auteurs

Sarah Threlfell (S)

Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.
Oxford Parkinson's Disease Centre, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.

Amir Saeid Mohammadi (AS)

Department of Chemistry and Chemical Engineering, Chalmers University of Technology, Gothenburg, Sweden.

Brent J Ryan (BJ)

Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.
Oxford Parkinson's Disease Centre, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.

Natalie Connor-Robson (N)

Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.
Oxford Parkinson's Disease Centre, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.

Nicola J Platt (NJ)

Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.

Rishi Anand (R)

Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.

Florence Serres (F)

University Department of Pharmacology, University of Oxford, Oxford, United Kingdom.

Trevor Sharp (T)

University Department of Pharmacology, University of Oxford, Oxford, United Kingdom.

Nora Bengoa-Vergniory (N)

Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.
Oxford Parkinson's Disease Centre, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.

Richard Wade-Martins (R)

Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.
Oxford Parkinson's Disease Centre, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.

Andrew Ewing (A)

Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.

Stephanie J Cragg (SJ)

Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.
Oxford Parkinson's Disease Centre, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.

Katherine R Brimblecombe (KR)

Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.
Oxford Parkinson's Disease Centre, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.

Classifications MeSH